LONDON: US drugmaker Pfizer is estimating generating $33.5 billion in sales to its COVID-19 vaccine after, forecasting the delivery of 500 million more doses compared with earlier expectations.
Pfizer, which has partnered with Germany’s BioNTech on the vaccine, forecasted $26 billion in sales in May.
According to Pfizer Chief Executive Albert Bourla, more than a billion doses of the vaccine have been delivered.
Read More
- Indian Social Club Oman marks India’s 80th Independence Day with grand celebration
- NCEM issues 4-step safety guidance for suspected contamination incidents in Oman
- Vehicle registrations in Oman reach nearly 1.9 million by end of June 2026
- Muscat Municipality opens new Qantab Walkway Project
- INS Imphal marks India’s 80th Independence Day during Muscat port call
